⚛️NRC Issues License Renewal for Virgil C. Summer Nuclear Station
The U.S. Nuclear Regulatory Commission (NRC) has issued Subsequent Renewed Facility Operating License No. NPF-12 to Dominion Energy South Carolina, Inc. (DESC, or the licensee), for Virgil C. Summer Nuclear Station, Unit 1 (V.C.Summer). In addition, the NRC has prepared a record of decision (ROD) that supports the NRC's decision to issue Subsequent Renewed Facility Operating License No. NPF-12.
Learn More📈Nasdaq Proposes Enhanced Closing Price Determination for ETPs
The Securities and Exchange Commission has announced a proposed rule change by Nasdaq to modify how the Official Closing Price (NOCP) is determined for exchange-traded products (ETPs) with less than one round lot traded. By adopting a time-weighted average price method, the proposal aims to provide a more accurate reflection of ETP values, particularly for those with lower trading volumes.
Learn More⚡Combined Notice of Filings Affecting Energy Sector Businesses
The Department of Energy issued a Combined Notice of Filings, detailing several exempt wholesale generator applications, initial rate filings, and compliance submissions by various energy companies. Businesses must be aware of these regulatory changes that could influence their operational and financial strategies in the energy market.
Learn More🏡HUD Rescinds Voter Registration Notice Affecting Public Housing
The Department of Housing and Urban Development announces that it is rescinding a March 7, 1996, Federal Register notice that provided guidance on efforts by Public Housing Agencies to promote voter registration in Public and Indian Housing.
Learn More📄Proposed Immigration Practitioner Complaint Form Collection Notice
The Executive Office for Immigration Review (EOIR), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Learn More✈️Proposed Airworthiness Directive for Airbus Helicopters EC 155B
The FAA proposes to adopt a new airworthiness directive (AD) for all Airbus Helicopters Model EC 155B and EC155B1 helicopters. This proposed AD was prompted by a determination that the required forces to jettison the windows exceed the maximum jettisoning effort requirements and the development of a modification of the jettisonable windows. This proposed AD would require replacement of the jettisonable windows and seals on the sliding doors and fixed panels on the left-hand and right- hand sides. This proposed AD would also require the installation of new labels. The FAA is proposing this AD to address the unsafe condition on these products.
Learn More📜Editorial Correction on Servicemembers' Life Insurance Regulations
The Department of Veterans Affairs has published a regulatory correction pertaining to Servicemembers' Group Life Insurance and Veterans' Group Life Insurance. This correction reinstates a definition regarding exclusions related to abortions, clarifying the scope of the coverage under Title 38 of the Code of Federal Regulations.
Learn More✈️Antitrust Concerns Over Safran's Acquisition of Collins Aerospace
The Department of Justice has fielded a complaint against Safran S.A.'s proposed acquisition of Collins Aerospace citing antitrust violations. The proposed Final Judgment requires Safran to divest its North American actuation business, ensuring the maintenance of competition in the aerospace sector for critical actuators used in large aircraft. Public comments are invited as part of the regulatory process.
Learn More🏦Regulatory Notice on Bank Holding Company Acquisitions and Mergers
This notice from the Federal Reserve System details applications for bank holding companies to acquire other banks and assets. It invites public comments on these applications and outlines the regulatory framework governing such mergers and acquisitions under the Bank Holding Company Act. Interested parties are encouraged to review and submit their views regarding the applications presented.
Learn More💊FDA Corrects Regulatory Review Period for ELREXFIO Patent
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register on May 12, 2025. The document, entitled "Determination of Regulatory Review Period for Purposes of Patent Extension; ELREXFIO," announced the determination of the regulatory review period for ELREXFIO (elranatamab-bcmm) for purposes of patent extension. The document was published with only one of two docket numbers. This document corrects that error.
Learn More